AwardedSpainGoods€6,360,080
Adquisición y suministro de forma centralizada de medicamentos de uso humano respetuoso con el medio ambiente que contiene los principios activos siguientes: bulevirtida, cabotegravir, dolutegravir y diferentes combinaciones con este principio activo, rilpivirina, darunavir/cobicistat, etravirina, rilpivirina y nirmatrelvir/ritonavir
- Published
- Published 29 June 2026
Overview
The procurement involved centralized acquisition and supply of environmentally-friendly human medicinal products containing the active ingredients bulevirtida, cabotegravir, dolutegravir and combinations thereof, rilpivirina, darunavir/cobicistat, etravirina, and nirmatrelvir/ritonavir for the Regional Health Authority. The contract was awarded on 25 May 2026 to four suppliers: Gilead Sciences, Janssen-Cilag, Laboratorios ViiV Healthcare, and Pfizer.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €6,360,080
- Procedure
- Direct
- Published
- 29 June 2026
Antivirals for systemic use
Award outcome
- Awarded value
- €0
- Award date
- 25 May 2026
- GILEAD SCIENCES, S.L.U
- JANSSEN-CILAG, S.A.
- LABORATORIOS ViiV HEALTHCARE, S.L.
- PFIZER, S.L.U.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
29 June 2026
Contracting authority
Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad
Procuring entityValencia, Spain
ID_PLATAFORMA: 20897030133463
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.